MARKET

BSX

BSX

Boston Scient
NYSE

Real-time Quotes | Nasdaq Last Sale

44.37
-0.53
-1.18%
After Hours: 44.57 +0.2 +0.45% 19:59 09/17 EDT
OPEN
44.53
PREV CLOSE
44.90
HIGH
44.71
LOW
43.92
VOLUME
8.42M
TURNOVER
--
52 WEEK HIGH
46.29
52 WEEK LOW
32.99
MARKET CAP
63.18B
P/E (TTM)
120.64
1D
5D
1M
3M
1Y
5Y
SVP And Human Resources Of Boston Scientific Makes $149.05 Thousand Sale
Wendy Carruthers, SVP And Human Resources at Boston Scientific (NYSE:BSX), made a large insider sell on September 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Ca...
Benzinga · 1d ago
'Fast Money Halftime Report' Picks For September 15
On CNBC's "Fast Money Halftime Report," Karen Firestone said Charles Schwab (NYSE: SCHW) has a lot of new young traders who have larger accounts than Robinhood Mar
Benzinga · 2d ago
Benign Prostatic Hyperplasia Treatment Market: Global Industry Size, Growth Rate, Emerging Trends, Regional Analysis and Research Report and Forecast to 2029
Research Nester released a report titled ": Global Demand Analysis & Opportunity Outlook 2029"which delivers detailed overview of the benign prostatic hyperplasia treatment market in terms of market segmentation by treatment type, application and region.
AmericaNewsHour · 2d ago
Percutaneous Coronary Intervention Market- Emerging Technologies, Trends, Industry Growth, Segments, Landscape and Demand by Forecast to 2027
Research Nester has released a reporttitled which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness, year-on-year (Y-O-Y) growth comparisons, market sh...
AmericaNewsHour · 3d ago
Remote Patient Monitoring Market – Strategic Plans by Globally Industry Demand, On Going Trends, Regional Overview, Business Growth and Forecast to 2027
Research Nester has released a report titled which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness, year-on-year (Y-O-Y) growth comparisons, market s...
AmericaNewsHour · 3d ago
Here's Why You Should Retain Boston Scientific (BSX) for Now
Zacks.com · 09/10 13:27
External Pacemaker Market Market Grow with a High CAGR Global Industry Analysis, And Key Players 2028
Research Nester has released a report titled "- Global Demand Analysis & Opportunity Outlook 2028" which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiven...
AmericaNewsHour · 09/10 08:50
NVST vs. BSX: Which Stock Should Value Investors Buy Now?
Zacks.com · 09/09 15:40
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BSX. Analyze the recent business situations of Boston Scient through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 32 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BSX stock price target is 51.08 with a high estimate of 57.00 and a low estimate of 41.00.
EPS
Institutional Holdings
Institutions: 1.15K
Institutional Holdings: 1.44B
% Owned: 100.98%
Shares Outstanding: 1.42B
TypeInstitutionsShares
Increased
291
61.79M
New
99
13.81M
Decreased
304
55.27M
Sold Out
56
11.42M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.54%
Healthcare Equipment & Supplies
+0.65%
Key Executives
Chairman/President/Chief Executive Officer/Director
Michael Mahoney
Chief Financial Officer/Executive Vice President
Daniel Brennan
Executive Vice President
Arthur Butcher
Executive Vice President
Joseph Fitzgerald
Executive Vice President
Edward Mackey
Executive Vice President
Ian Meredith
Executive Vice President
Jeffrey Mirviss
Executive Vice President
David Pierce
Executive Vice President
Eric Thepaut
Senior Vice President/Chief Information Officer
Jodi Eddy
Senior Vice President/General Counsel/Secretary
Desiree Rallsmorrison
Senior Vice President/Director of Human Resources
Wendy Carruthers
Senior Vice President
Maulik Nanavaty
Senior Vice President
Scott Olson
Senior Vice President
Meghan Scanlon
Senior Vice President
John Sorenson
Lead Director/Independent Director
Edward Ludwig
Director
David Wichmann
Independent Director
Nelda Connors
Independent Director
Charles Dockendorff
Independent Director
Yoshiaki Fujimori
Independent Director
Donna James
Independent Director
David Roux
Independent Director
John Sununu
Independent Director
Ellen Zane
No Data
About BSX
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.

Webull offers kinds of Boston Scientific Corporation stock information, including NYSE:BSX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BSX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BSX stock methods without spending real money on the virtual paper trading platform.